Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-28 @ 10:41 AM
Study NCT ID:
NCT00066768
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2003-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)